← Browse by Condition
Medical Condition

paraproteinemias

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06889948 Phase 2
Recruiting

The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

Enrollment
30 pts
Location
Finland
Sponsor
Helsinki University Central Ho...
View Trial →